Professor Rachel Butler is a Consultant Clinical Scientist and Chief Operating Officer of the North Thames Genomic Laboratory Hub (GLH). The North Thames GLH is one of seven GLHs in England responsible for providing genomic and genetic testing, including whole genome sequencing, as part of the genomic medicine service in the NHS. The North Thames GLH provides all core rare and inherited disease, many specialist disease, and cancer genomic testing services for the population of north, west and east London, and parts of Essex and Hertfordshire.
Rachel has previously led on Cancer Research UK’s Stratified Medicine Programme and been a grant holder for a number of stratified medicine clinical trials. She is a Fellow of the Royal College of Pathologists in Molecular Genetics, and was the Lead Examiner for Molecular Pathology. She is currently the co-chair of the NHS England Cancer Test Directory Evaluation Group, and sits on the Clinical Reference Group for Genomics. She was awarded an MBE in 2017 for services to Genomics in Wales and the UK.